MaxCyte Inc's (LON:MXCT) Doug Doerfler speaks to investors at the Proactive One2One Virtual Event. They're a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. For more information visit www.maxcyte.com
MaxCyte Inc - Proactive One2One Virtual Event
Quick facts: MaxCyte Inc
Price: 980 GBX
Market Cap: £828.65 m
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of MaxCyte Inc named herein, including the promotion by the Company of MaxCyte Inc in any Content on the Site, the Company receives from said...FOR OUR FULL DISCLAIMER CLICK HERE